| |
| |
|
| Insider
Information: |
Fardis Maria |
| Relationship: |
President and CEO, Dir... |
| City: |
Sunnyvale |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
301,979 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,059,569 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
301,979 |
|
|
| Total
Value |
$3,059,569 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Pharmacyclics Inc |
PCYC |
Chief of Oncology Ops ... |
2014-11-13 |
3,193 |
|
0 |
Premium* |
|
|
Iovance Biotherapeutics Inc |
IOVA |
President and CEO, Dir... |
2020-06-01 |
298,786 |
2016-06-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
55 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PCYC |
Pharmacyclics Inc |
EVP, Operations and AlliancesO |
• – – |
2012-09-24 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,149 |
|
- |
|
| IOVA |
Iovance Biotherapeutics I... |
President & CEO |
• • – |
2016-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
550,000 |
550,000 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
President and CEO |
• • – |
2017-06-01 |
4 |
D |
$5.45 |
$782,053 |
D/D |
(143,496) |
354,831 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
President and CEO |
• • – |
2017-08-01 |
4 |
D |
$5.70 |
$11,360 |
D/D |
(1,993) |
350,844 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
President and CEO |
• • – |
2017-09-01 |
4 |
D |
$6.00 |
$11,964 |
D/D |
(1,994) |
348,850 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
EVP, Operations and Alliances |
• – – |
2013-01-07 |
4 |
OE |
$6.84 |
$23,940 |
D/D |
3,500 |
6,976 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
Chief of Oncology Ops & Allian |
• – – |
2014-03-05 |
4 |
OE |
$6.84 |
$20,520 |
D/D |
3,000 |
5,988 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
Chief of Oncology Ops & Allian |
• – – |
2014-08-13 |
4 |
OE |
$6.84 |
$27,360 |
D/D |
4,000 |
7,192 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
Chief of Oncology Ops & Allian |
• – – |
2014-11-07 |
4 |
OE |
$6.84 |
$34,200 |
D/D |
5,000 |
8,193 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
Chief of Oncology Ops & Allian |
• – – |
2014-11-13 |
4 |
OE |
$6.84 |
$20,520 |
D/D |
3,000 |
6,193 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
President and CEO |
• • – |
2017-04-03 |
4 |
D |
$7.15 |
$369,462 |
D/D |
(51,673) |
498,327 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
President and CEO |
• • – |
2017-11-01 |
4 |
D |
$7.15 |
$14,257 |
D/D |
(1,994) |
344,863 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
President and CEO |
• • – |
2017-07-01 |
4 |
D |
$7.35 |
$14,656 |
D/D |
(1,994) |
352,837 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
President and CEO |
• • – |
2017-10-01 |
4 |
D |
$7.75 |
$15,446 |
D/D |
(1,993) |
346,857 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
President and CEO |
• • – |
2018-01-01 |
4 |
D |
$8.00 |
$12,496 |
D/D |
(1,562) |
341,307 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
President and CEO |
• • – |
2017-12-01 |
4 |
D |
$8.80 |
$17,547 |
D/D |
(1,994) |
342,869 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
President and CEO |
• • – |
2019-02-01 |
4 |
D |
$9.26 |
$14,464 |
D/D |
(1,562) |
323,448 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
President and CEO |
• • – |
2019-01-02 |
4 |
D |
$9.45 |
$14,761 |
D/D |
(1,562) |
325,010 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
President and CEO |
• • – |
2018-11-01 |
4 |
D |
$9.62 |
$12,708 |
D/D |
(1,321) |
327,893 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
President and CEO |
• • – |
2019-04-01 |
4 |
D |
$9.78 |
$12,919 |
D/D |
(1,321) |
320,829 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
President and CEO |
• • – |
2018-12-01 |
4 |
D |
$10.44 |
$13,791 |
D/D |
(1,321) |
326,572 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
EVP, Operations and Alliances |
• – – |
2012-10-31 |
4 |
A |
$10.56 |
$3,452 |
D/D |
327 |
3,476 |
0 |
- |
|
| PCYC |
Pharmacyclics Inc |
Chief of Oncology Ops & Allian |
• – – |
2013-04-30 |
4 |
A |
$10.56 |
$21,241 |
D/D |
2,012 |
2,988 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
President and CEO |
• • – |
2019-03-01 |
4 |
D |
$10.77 |
$13,979 |
D/D |
(1,298) |
322,150 |
0 |
- |
|
| IOVA |
Iovance Biotherapeutics I... |
President and CEO |
• • – |
2018-10-01 |
4 |
D |
$11.12 |
$14,690 |
D/D |
(1,321) |
329,214 |
0 |
- |
|
55 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
